Your browser doesn't support javascript.
loading
Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72.
Cabral-Miranda, Gustavo; Lim, Stephanie M; Mohsen, Mona O; Pobelov, Ilya V; Roesti, Elisa S; Heath, Matthew D; Skinner, Murray A; Kramer, Matthias F; Martina, Byron E E; Bachmann, Martin F.
Afiliação
  • Cabral-Miranda G; The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK.
  • Lim SM; Immunology, RIA, Inselspital, University of Bern, 3010 Bern, Switzerland.
  • Mohsen MO; Artemis Bio-Support, Molengraaffsingel, 2629 Delft, The Netherlands.
  • Pobelov IV; The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK.
  • Roesti ES; Immunology, RIA, Inselspital, University of Bern, 3010 Bern, Switzerland.
  • Heath MD; Department of Chemistry and Biochemistry, University of Bern, 3010 Bern, Switzerland.
  • Skinner MA; Immunology, RIA, Inselspital, University of Bern, 3010 Bern, Switzerland.
  • Kramer MF; Bencard Adjuvant Systems, Worthing BN14 8SA, UK.
  • Martina BEE; Bencard Adjuvant Systems, Worthing BN14 8SA, UK.
  • Bachmann MF; Bencard Adjuvant Systems, Worthing BN14 8SA, UK.
Vaccines (Basel) ; 8(1)2020 Feb 20.
Article em En | MEDLINE | ID: mdl-32093400

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article